Background: The inflammatory hypothesis of schizophrenia is not new, but recently it has
regained interest because more data suggest a role of the immune system in the …

BackgroundAccumulating evidence shows that a propensity towards a pro-inflammatory
status in the brain plays an important role in schizophrenia. Anti-inflammatory drugs might …

Background: Inflammation plays a major role in the onset and maintenance of
schizophrenia. The objective of the present work was to synthetize in a narrative review the …

Schizophrenia is a chronic debilitating mental disorder that affects about 1% of the US
population. The pathophysiology and etiology remain unknown, thus new treatment targets …

Objective: Mounting evidence suggests that inflammation is involved in the pathogenesis of
schizophrenia. This evidence implies that anti-inflammatory agents are potentially useful …

Objective: Recent evidence suggests that adjuvant anti-inflammatory agents could improve
the symptoms of patients with schizophrenia. However, the effects of the adjuvant anti …

Aim Over the past several decades, there has been a growing research interest in the role of
inflammation in the pathogenesis of schizophrenia. This review aims to summarize evidence …

In recent years, there is a new optimism in schizophrenia therapeutics with the emergence of
immunomodulation as a potential treatment approach. Current evidence points to various …

Schizophrenia is a debilitating psychiatric disorder with a substantial socioeconomic and
humanistic burden. Currently available treatment strategies mostly rely on antipsychotic …

Objectives Evidence-based medicine suggests that schizophrenia is associated with an
inflammatory syndrome, but the extent to which this syndrome is normalized by antipsychotic …